Briefcases -- All Litigations -- PRADAXA MDL 2385
PRADAXA MDL 2385
Case Files
News
Chat
Easy Button
Committees

Categories

  1. Pradaxa MDL 2385 Pretrial Orders
  2. Pradaxa Status Conference Transcripts
  3. Pradaxa Settlement Documents
  4. Pradaxa Case Management Orders
  5. Pradaxa Plaintiffs Leadership
  6. Pradaxa MDL Status Conference Transcripts
  7. Pradaxa Safety Label Changes Link
  8. Link to Pradaxa MDL 2385 Court
  9. Pradaxa FDA Approval History
  10. Pradaxa FDA Links
  11. Pradaxa Safety Label Changes Link
  12. Pradaxa Court Contacts
View All

Documents

  1. Pradaxa MSA.pdf
  2. MDL 2385 - Pradaxa Lead Counsel List Microsoft Word Document.docx
  3. MDL 2385 - Pradaxa Liaison Counsel List Microsoft Word Document.docx
  4. MDL 2385 - Pradaxa Court Contacts Microsoft Word Document.docx
  5. CMO 1 Initial Conference Order and Procedural Matters.pdf
  6. CMO 2 Amended Order No 2 - Exhibit A.pdf
  7. CMO 2 Amended Order No 2- onfidentiality Order [Vacating and Replacing Doc. 5].pdf
  8. CMO 2 Minute Order 86 Re: CMO No 2.pdf
  9. CMO 4 Order No 4-Appointing Plaintiffs' Leadership Positions.pdf
  10. CMO 5 Appointing Defendants' Leadership Positions.pdf
  11. CMO 6 Unified Case Management Plan.pdf
  12. CMO 6 Minute Order 11.pdf
  13. CMO 7 Direct Filing and Waiver of Service of Process for Direct Filed Cases.pdf
  14. CMO 8 Deposition Protocol.pdf
  15. CMO 9 Notification to Clerk of Motions Pending in Transferred Actions.pdf
  16. CMO 10 Extension of Responsive Pleading Deadlines.pdf
  17. CMO 11 Unified Case Management Plan for BOEHRINGER INGELHEIM INTERNATIONAL GmbH.pdf
  18. CMO 12 Regarding Foreign Defendants Direct Filing & Waiver of Service-Process-Federal Cases Against BOEHRINGER INGELHEIM INTERNATIONAL GmbH.pdf
  19. CMO 13 Regarding Deposition Protocol of Boehringer Ingelheim International GmbH &Dismissed Foreign Defendants' Witnesses.pdf
  20. CMO 14 Appointing State-Federal Liaison Counsel.pdf
  21. CMO 15 Exhibit A.pdf
  22. CMO 15 Second Amended-Regarding Plaintiff Fact Sheets.pdf
  23. CMO 16 Establishing Common Benefit Fee and Expense Fund and Exhibit A.pdf
  24. CMO 16 Minute Order 67 Amending Case Management Order No 16 and E.pdf
  25. CMO 17 Amended Order No. 17 - Production Schedule for BIPI.pdf
  26. CMO 18 Production Schedule for BII.pdf
  27. CMO 19 Regarding BIPI's Motion for a Protective Order.pdf
  28. CMO 20 Regarding Defendant Fact Sheets for BIPI and Exhibit A.pdf
  29. CMO 21 Plaintiffs' Additional Custodial Records Requests Served on December 28, 2012 and January 21, 2013.pdf
  30. CMO 22 Confidentiality of Certain Databases.pdf
  31. CMO 23 Concerning Claims of Privilege by Plaintiffs, BIPI, and BII.pdf
  32. CMO 24 Deadlines to Answer, Otherwise Plead, or Respond/Reply to Pending Motions in Cases Transferred to MDL 2385.pdf
  33. CMO 25 Lifting Responsive Pleading Stay.pdf
  34. CMO 27 Entries of Appearance for Non-Lead and Non-Liaison Counsel Participating in Depositions or Oral Argument.pdf
  35. CMO 28 Amended-Early Trial Scheduling.pdf
  36. CMO 29-Modifying Prior Case Management Orders to Provide BII More Time to Make Required Productions.pdf
  37. CMO 30 Production of BIPI Employee Personnel Files.pdf
  38. CMO 31 Regarding Discovery of Documents Reviewed by Deponents.pdf
  39. CMO 32 Amended Order Consent Order Extending Certain Responsive Pleading Deadlines and Striking and Replacing CMO 32.pdf
  40. CMO 34 Granting Motion for Letter Rogatory to Obtain Documentary Evidence From Population Health Research Institute ("PHRI") in Canada.pdf
  41. CMO 35 Vacated per Minute Order 222 Order No. 35-Pre-Identification of Exhibits to be used in Depositions.pdf
  42. CMO 35 Minute Order 201 Staying the Enforcement of Case Management.pdf
  43. CMO 37 Modifying Prior Case Managment Orders.pdf
  44. CMO37 Order Denying Defendants' Letter Request to Reconsider CMO 37.pdf
  45. CMO 38-Regarding Proposed Revisions to Production and Pretrial Scheduling.pdf
  46. CMO 39 Appointing Mediator.pdf
  47. CMO 40 Exhibit B BII Short Form.pdf
  48. CMO 40 Exhibit A BIPI Short Form.pdf
  49. CMO 40 Defendants' Master Short Form Answers.pdf
  50. CMO 41 Appointment of Special Master.pdf
  51. CMO 42 Ex Parte Communications Treating Physicians.pdf
  52. CMO 43 Discovery Special Master.pdf
  53. CMO 44 Attendance at Discovery Dispute Conference.pdf
  54. CMO 45 Motion to Compel Wael Hashad Custodial Documents.pdf
  55. CMO 46 Amending Paragraph 9 of CMO 37.pdf
  56. CMO 47 New Appointments - Plaintiffs' Leadership Positions.pdf
  57. CMO 48 Selecting Cases for Consideration as Early Trial Cases.pdf
  58. CMO 49-Production Scehdule.pdf
  59. CMO 50 Regarding PSC's Second Motion for Sanctions.pdf
  60. CMO 50-1 Regarding BII's Certification as to Professor Thorstein Lehr.pdf
  61. CMO 51 Regarding Motion to Compel.pdf
  62. CMO 51 Minute Order.pdf
  63. CMO 52 Second Amended Order No 52 - Bellwether Selections.pdf
  64. CMO 53 Denying Protective Order.pdf
  65. CMO 54 Rescinding CMO 50.pdf
  66. CMO 55 Appointment of Substitute Special Master.pdf
  67. CMO 56 Exhibit A - Challenged Documents.pdf
  68. CMO 56 Confidentiality Designations.pdf
  69. CMO 57 February 5, 2014, Phone Hearing.pdf
  70. CMO 58 Regarding RE-LY Discovery Issue.pdf
  71. CMO 59 Regarding Defendants' Motion for Protective Order (Deposition Conduct).pdf
  72. CMO 60 Modifying Portions of CMOs 28 and 46 Including Modification of Bellwether Trial Dates.pdf
  73. CMO 62 Regarding the PSC's Second Motion for Sanctions Addressing the Matter of Monetary Sanctions Only.pdf
  74. CMO 64 Pre-trial Schedule For First MDL Trial.pdf
  75. CMO 65 Addressing Motions Challenging Certain Confidentiality Designations.pdf
  76. CMO 65 Minute Order.pdf
  77. CMO 67 Pre-trial Schedule For Second MDL Trial (Primus).pdf
  78. CMO 68 Modifying CMO No. 60.pdf
  79. CMO 69 Regarding RE-LY Discovery.pdf
  80. CMO 70 Modification of CMO 68 as it pertains to the first MDL trial.pdf
  81. CMO 71 Modification of CMO 68 as it pertains to plaintiffs' expert reports deadline.pdf
  82. CMO 72 Modification of CMO 68 as it pertains to plaintiffs' expert reports deadline.pdf
  83. CMO 73 Staying of all cases until further notice.pdf
  84. CMO 74 Appointing Pradaxa Claimants' Negotiating Committee.pdf
  85. CMO 75 Re: Delaware State Court Cases.pdf
  86. CMO 76 Initial Claimant Identification Certification Order.pdf
  87. CMO 76 Exhibit A-Initial Claimant Identification Certification Exhibit A.pdf
  88. CMO 77 Duties of the Claims Administrator and the Special Master.pdf
  89. CMO 78 Requirements for Preservation of Records and Prima Facie Evidence of Usage, Injury and Causation.pdf
  90. CMO 79 Modification to CMO 73.pdf
  91. CMO 80 Procedure for Handling of Obsolete Materials by Defendants.pdf
  92. CMO 81 Appointing Providio Lien Counsel To Establish Medicare Global Lien Resolution Model.pdf
  93. CMO 82 Establishing Qualified Settlement Fund for Pradaxa Resolution Program.pdf
  94. CMO 83 Change in Funding Requirements and Master Settlement Agreement.pdf
  95. CMO 84 STRICKEN Order No. 84 - Regarding Resolution of Private Lien Interests.pdf
  96. CMO 85 Procedure for Filing Qualified Settlement Fund Motions.pdf
  97. CMO 86 Resolution of Cases Involving the Death or Incapacity of a Product User.pdf
  98. CMO 87 Striking Case Management Order 84.pdf
  99. CMO 88 Phase One Payment Allocations.pdf
  100. CMO 89 Denying Motion to Stay and Prohibiting Discovery Relating to Common Benefit Fee Determination.pdf
  101. CMO 90 Amended Stipulations-Dismissal-Matters Settled Under the Pradaxa Product Liability Lit. Master Settlement Agreement (Ex A Rev 01/21/2015).pdf
  102. CMO 91 Regarding Motion to Clarify & Amend, & Alternatively, Stay & Amend, CMO 88.pdf
  103. CMO 92 Granting Motion to Authorize Common Benefit Expenses.pdf
  104. CMO 93 Granting Second Motion to Authorize Common Benefit Expense.pdf
  105. CMO 94 Preservation Matters.pdf
  106. CMO 95 Regarding Common Benefit Matters.pdf
  107. CMO 96 Minute Order.pdf
  108. CMO01212015.pdf
  109. 1-14-2013 Status Conference.pdf
  110. 1-24-2014 Status Conference.pdf
  111. 2-05-2014 Teleconference.pdf
  112. 2-07-2013 Status Conference.pdf
  113. 2-18-2015 Status Conference.pdf
  114. 3-05-2014 Teleconference.pdf
  115. 3-08-2013 Hearing.pdf
  116. 3-14-2013 Status Conference.pdf
  117. 4-09-2014 Status Conference.pdf
  118. 4-15-2013 Status Conference.pdf
  119. 5-02-2014 Status Conference.pdf
  120. 5-14-2013 Status Conference.pdf
  121. 6-10-2013 Status Conference.pdf
  122. 6-12-2014 Status Conference.pdf
  123. 7-09-2013 Status Conference.pdf
  124. 7-28-2014 Status Conference.pdf
  125. 8-08-2013 Status Conference.pdf
  126. 8-26-2014 Status Conference.pdf
  127. 9-04-2013 Status Conference.pdf
  128. 9-18-2013 Status Conference.pdf
  129. 9-29-2014 Motion Hearing.pdf
  130. 9-29-2014 Status Conference.pdf
  131. 10-03-2012 Initial Conference.pdf
  132. 12-13-2012 Status Conference.pdf
  133. 10-08-2013 Status Conference.pdf
  134. 11-05-2012 Status Conference.pdf
  135. 11-18-2013 Status Conference.pdf
  136. 12-20-2013 Teleconference.pdf
  137. 11-12-2014 Status Conference.pdf
  138. 12-18-2014 Status Conference.pdf
  139. Status Conference 04282015.pdf
  140. Second Amended Order No. 52 - Bellwether Selections.pdf
  141. Second Amended Order No. 15 - Regarding Plaintiff Fact Sheet.pdf
  142. Resolution of Cases Involving the Death or Incapacity of a Product User.pdf
  143. Regarding Discovery of Documents Reviewed by Deponents.pdf
  144. Regarding Defendant Fact Sheets for BIPI and Exhibit A.pdf
  145. Production of BIPI Employee Personnel Files.pdf
  146. Pre-Identification of Exhibits to be used in Depositions.pdf
  147. Order No. 88 - Phase One Payment Allocations.pdf
  148. Order No. 87 - Striking Case Management Order 84.pdf
  149. Order No. 85 - Procedure for Filing Qualified Settlement Fund Motions.pdf
  150. Order No. 79 - Modification to CMO 73.pdf
  151. Order No. 77 - Duties of the Claims Administrator and the Special Master.pdf
  152. Order No. 76 - Initial Claimant Identification Certification Order.pdf
  153. Order No. 76 - Exhibit A - Initial Claimant Identification Certification.pdf
  154. Order No. 75 - Re Delaware State Court Cases.pdf
  155. Order No. 74 - Appointing Pradaxa Claimants' Negotiating Committee.pdf
  156. Order No. 73 - Staying of all cases until further notice.pdf
  157. Order No. 69 - Regarding RE-LY Discovery.pdf
  158. Order No. 68 - Modifying CMO No. 60.pdf
  159. Order No. 67 - Pre-trial Schedule For Second MDL Trial (Primus).pdf
  160. Order No. 64 - Pre-trial Schedule For First MDL Trial.pdf
  161. Order No. 58 - Regarding RE-LY Discovery Issue.pdf
  162. Order No. 57 - February 5, 2014, Phone Hearing.pdf
  163. Order No. 56 - Exhibit A - Challenged Documents.pdf
  164. Order No. 56 - Confidentiality Designations.pdf
  165. Order No. 55 - Appointment of Substitute Special Master.pdf
  166. Order No. 54 - Rescinding CMO 50.pdf
  167. Order No. 53 - Denying Protective Order.pdf
  168. Order No. 51 - Regarding Motion to Compel.pdf
  169. Order No. 50 - Regarding PSC's Second Motion for Sanctions.pdf
  170. Order No. 49 - Production Scehdule.pdf
  171. Order No. 48 - Selecting Cases for Consideration as Early Trial Cases.pdf
  172. Order No. 47 - New Appointments - Plaintiffs' Leadership Positions.pdf
  173. Order No. 46 - Amending Paragraph 9 of CMO 37.pdf
  174. Order No. 45 - Motion to Compel Wael Hashad Custodial Documents.pdf
  175. Order No. 44 - Attendance at Discovery Dispute Conference.pdf
  176. Order No. 43 - Discovery Special Master.pdf
  177. Order No. 42 - Ex Parte Communications Treating Physicians.pdf
  178. Order No. 41 - Appointment of Special Master.pdf
  179. Order No. 39 - Appointing Mediator.pdf
  180. Order No. 37 - Modifying Prior Case Managment Orders.pdf
  181. Order No. 30 - Production of BIPI Employee Personnel Files.pdf
  182. Order No. 19 - Regarding BIPI's Motion for a Protective Order.pdf
  183. Order No. 18 - Production Schedule for BII.pdf
  184. Order No. 16 - Establishing Common Benefit Fee and Expense Fund.pdf
  185. Order No. 15 - Exhibit A.pdf
  186. Order No. 14 - Appointing State-Federal Liaison Counsel.pdf
  187. Order No. 10 - Extension of Responsive Pleading Deadlines.pdf
  188. Order No. 6 - Unified Case Management Plan.pdf
  189. Order No. 5 - Appointing Defendants' Leadership Positions.pdf
  190. Order No. 4 - Appointing Plaintiffs' Leadership Positions.pdf
  191. Order Denying Defendants' Letter Request to Reconsider CMO 37.pdf
  192. Minute Order 67 Amending Case Management Order No. 16.pdf
  193. Lifting Responsive Pleading Stay.pdf
  194. Initial Conference Order and Procedural Matters.pdf
  195. Exhibit B BII Short Form.pdf
  196. Exhibit A.pdf
  197. Exhibit A BIPI Short Form.pdf
  198. Exhibit A - Challenged Documents.pdf
  199. Direct Filing and Waiver of Service of Process for Direct Filed Cases.pdf
  200. Deposition Protocol.pdf
  201. Defendants' Master Short Form Answers.pdf
  202. Confidentiality Order [Vacating and Replacing Doc. 5].pdf
  203. Confidentiality of Certain Databases.pdf
  204. Confidentiality Designations.pdf
  205. Concerning Claims of Privilege by Plaintiffs, BIPI, and BII.pdf
  206. Appointing Plaintiffs' Leadership Positions.pdf
  207. Appointing Defendants' Leadership Positions.pdf
  208. Amended Order No. 28 - Early Trial Scheduling.pdf
  209. Amended Order No. 17 - Production Schedule for BIPI.pdf
  210. Amended Order No. 3 - Regarding Format of Production and Attachment A.pdf
  211. Addressing Motions Challenging Certain Confidentiality Designations.pdf
  212. 2385minutes10032012.pdf
  213. minutes01142013.pdf
  214. Minutes01242014.pdf
  215. minutes02052014.pdf
  216. minutes02072013.pdf
  217. minutes02182015.pdf
  218. minutes03052014.pdf
  219. Minutes03082013.pdf
  220. minutes03142013.pdf
  221. Minutes04092014.pdf
  222. minutes04152013.pdf
  223. minutes04282015.pdf
  224. Minutes05022014.pdf
  225. minutes05142013.pdf
  226. minutes06102013.pdf
  227. Minutes06122014.pdf
  228. minutes07092013.pdf
  229. minutes07282014.pdf
  230. minutes08082013.pdf
  231. minutes08262014.pdf
  232. Minutes09042013.pdf
  233. minutes09182013.pdf
  234. Minutes09292014MotionHearing.pdf
  235. Minutes09292014Pradaxa.pdf
  236. Minutes10082013.pdf
  237. minutes11052012.pdf
  238. Minutes11122014.pdf
  239. minutes11182013Pradaxa.pdf
  240. minutes12132012.pdf
  241. Minutes12182014.pdf
  242. Minutes12202013.pdf
  243. Pradaxa FDA Approval History
  244. Pradaxa FDA Links
  245. Pradaxa FDA Links
View All

Discussion

    No Recent Messages
Add Comment